Executive Leadership Team

David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors since May 2018. From 2016 to 2018, David served as Senior VP at Allergan, Inc., and division head of the U.S. Medical Aesthetics division, which included facial aesthetics, plastic surgery and skin care products. Prior to that, David worked in various leadership capacities within Allergan since 2005, including as VP, Sales and Marketing of the U.S. Facial Aesthetics division and VP, Sales and Marketing of the U.S. Plastic Surgery division. Before Allergan, David was a district manager at Novartis Pharmaceuticals for the Dermatology division. He holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Sandra Beaver joined Evolus in September 2022 as Chief Financial Officer. Prior to Evolus, Sandra served as Senior Vice President of Finance at Experian, a global information services company, where she was responsible for half the company’s North America B2B business units. Before Experian, she spent 17 years at International Game Technology PLC, where she held roles with increasing levels of responsibility and scope including Vice President of Consolidated Financial Planning & Analysis, and Vice President and Chief Financial Officer of the company’s North America Gaming and Interactive business unit. Sandra holds a B.A. in Finance and Economics from the Isenberg School of Management at the University of Massachusetts Amherst.

Rui Avelar, M.D., has served as our Chief Medical Officer since January 2014 and was also named Head of Research and Development in August 2018.  From 2014 to 2018, he also served as the Chief Medical Officer of ALPHAEON.  From 2011 to 2013, Rui served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Rui holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine. 

Jeff Plumer joined Evolus in 2014 as VP, Legal and Corporate Secretary and was promoted to General Counsel in November 2020. Previously, he was a corporate attorney at K&L Gates, a fully integrated law firm located across five continents, where he worked on a wide range of legal matters including mergers and acquisitions, capital markets transactions, corporate governance issues and intellectual property transactions. Jeff received his J.D. from the University of California, Davis School of Law and his B.A. from the University of Colorado at Boulder.

Jessica Novak joined Evolus in November 2021 as Senior Vice President, Human Resources. Prior to Evolus, Jessica was Senior Vice President in charge of total rewards, organizational and talent development, and learning and culture functions at RGP, a next-generation global human capital firm. Prior to RGP, Jessica was the global head of HR and a member of the Executive Leader Team at Ambry Genetics and has additional experience in the manufacturing, pharmaceuticals, and education industries. A board member of the National Human Resource Association, Jessica earned a B.S. in Psychology and Sociology with a minor in Business Administration at the University of Oregon. She also earned her M.S. in Human Resources Management at Chapman University.

Kurt Knab joined Evolus in August 2018 as Vice President of Sales. Prior to Evolus, Kurt served as VP of Sales at Medline Industries, a privately held manufacturer and distributor of medical supplies. Before Medline, Kurt held multiple sales leadership roles at Lifecell Corporation culminating in VP of Sales. Kurt has more than two decades of experience in the medical and aesthetic industries. He earned his B.S. in Marketing from Pennsylvania State University.